The role of topotecan in cancer ginecology treatment

The role of topotecan in cancer ginecology treatment

The high morbidity, often latent, asymptomatic disease development is not optimal therapy in the first line, causes the development of the frequent recurrence of tumors, requiring second and thirds lines of chemotherapy. The use of topotecan in standard mode is limited by myelosuppression, therefore...

書目詳細資料
Main Authors:	A. G. Kedrova, V. V. Kosyy, D. A. Astakhov
格式:	Article
語言:	Russian
出版:	ABV-press 2017-02-01
叢編:	Опухоли женской репродуктивной системы
主題:	relapse of ovarian cancer endometrium cancer cervix cancer topotecan bevacizumab weekly regimen
在線閱讀:	https://ojrs.abvpress.ru/ojrs/article/view/525

相似書籍

The leadership of topotecan in the treatment of recurrent platinum-resistant ovarian cancer
由: K. E. Borisov
出版: (2014-07-01)

The use of weekly topotecan in the treatment of heavily pretreated recurrent epithelial ovarian and primary peritoneal cancer: The Kaohsiung Chang Gung experience
由: Ching-Fen Hu, et al.
出版: (2015-02-01)

Recurrent ovarian cancer: prolongation of the platinum-free interval with the use of a weekly treatment regimen of hycamtin (topotecan)
由: E. G. Novikova, et al.
出版: (2014-07-01)

Weekly topotecan regimen in the treatment of recurrent ovarian cancer: search for alternatives to upholding the quality of life
由: E. G. Novikova, et al.
出版: (2014-08-01)

Therapeutic uses of topotecan for thoracic malignancies
由: Saoirse O. Dolly, et al.
出版: (2011-12-01)

New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines
由: Monika Świerczewska, et al.
出版: (2017-10-01)

Comparison of clinico-pathological characteristics and survival of recurrent ovarian cancer patients on seven different chemo-protocols
由: Sattar Saima, et al.
出版: (2019-03-01)

OUR EXPERIENCE WITH TOPOTECAN AS SECOND- LINE TREATMENT OF PATIENTS WITH RELAPSED SMALL CELL LUNG CANCER
由: Deyan Davidov
出版: (2010-11-01)

Intra‐CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases
由: Kurt A. Jaeckle, et al.
出版: (2020-11-01)

Hyaluronic acid–targeted topotecan liposomes improve therapeutic efficacy against lung cancer in animals
由: Gangqiang Xue, et al.
出版: (2024-12-01)

A preliminary study on combination therapy of artemisinin dimer oxime and topotecan against nonsmall cell lung cancer in mice
由: Mohammad K Ashfaq, et al.
出版: (2018-01-01)

Ovarian cancer: new accents treatment of patients with platinum-sensitive relapses
由: A. G. Kedrova, et al.
出版: (2016-11-01)

Propensity Score Matched Study of Tri-Weekly vs. Weekly Platinum-Based Chemotherapy Concurrent with Radiotherapy in the Treatment of Locally Advanced Cervical Cancer
由: Kullathorn Thephamongkhol, et al.
出版: (2022-04-01)

Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells
由: Teresa Di Desidero, et al.
出版: (2019-11-01)

Is the routine use of bevacizumab in the treatment of women with advanced or recurrent cancer of the cervix sustainable?
由: Klag N, et al.
出版: (2016-06-01)

Topotecan inhibits metastasis of non-small cell lung cancer by regulating epithelial-mesenchymal transition
由: Zhen Liu, et al.
出版: (2022-08-01)

Micellar paclitaxel in the treatment of patients with tumors of the female reproductive system
由: A. G. Kedrova, et al.
出版: (2019-11-01)

Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer: a systematic review and economic evaluation
由: Steven J Edwards, et al.
出版: (2015-01-01)

Periocular topotecan for vitreous seeds in retinoblastoma
由: Purnima R Sthapit, et al.
出版: (2018-01-01)

Adverse drug reaction after intravitreal injection of topotecan
由: Subina Narang, et al.
出版: (2020-01-01)

Three Weekly Versus Weekly Cisplatin: Comparison of two Different Chemotherapy Protocols with Concurrent Radiotherapy in Locally Advanced Head and Neck Cancer
由: Sankalp Singh, et al.
出版: (2022-05-01)

Is Intravenous and Oral Topotecan in Small-Cell Lung Cancer Truly Equal? A Case Report
由: Davien Deraedt, et al.
出版: (2024-10-01)

Immediate Versus Delayed Topotecan after First-line Therapy in Small Cell Lung Cancer
由: Cong XUE, et al.
出版: (2010-03-01)

Uso de Topotecan no tratamento do Tumor Epitelial de Ovário Refratário à Platina: Experiência do INCA
由: Luiz Henrique de Lima Araújo, et al.
出版: (2008-06-01)

Topotecan in a Real-World Small-Cell Lung Cancer Cohort: Prognostic Biomarkers Improve Selection of Patients for Second-Line Treatment
由: Laura Lambrecht, et al.
出版: (2024-07-01)

Convection Enhanced Delivery of Topotecan for Gliomas: A Single-Center Experience
由: Pavan S. Upadhyayula, et al.
出版: (2020-12-01)

The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation
由: E Loveman, et al.
出版: (2010-03-01)

Intravitreal topotecan inhibits laser-induced choroidal neovascularization in a rat model
由: Mohammad Ali Gholipour, et al.
出版: (2015-01-01)

Bevacizumab in maintenance therapy for ovarian cancer patients
由: L. Yu. Vladimirova, et al.
出版: (2020-08-01)

Topoisomerase I inhibitor suppress tumor growth in chemoresistant ovarian cancer-initiating cells
由: Yu-Chi Wang, et al.
出版: (2014-01-01)

The Role of Cryotherapy in Vitreous Concentrations of Topotecan Delivered by Episcleral Hydrogel Implant
由: Martina Kodetova, et al.
出版: (2022-04-01)

Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer
由: Vincenza Conteduca, et al.
出版: (2018-12-01)

Clinical case use bevacizumab for patient with metastatic ovarian cancer
由: M. R. Oganyan, et al.
出版: (2014-07-01)

Modern aspects of antiangiogenic therapy in ovarian cancer
由: A. A. Rumyantsev, et al.
出版: (2018-11-01)

Management of Relapsed/Refractory Epithelial Ovarian Cancer: Current Standards and Novel Approaches
由: Hao Lin, et al.
出版: (2007-12-01)

Optimising the treatment of the partially platinum-sensitive relapsed ovarian cancer patient
由: Nicoletta Colombo
出版: (2014-12-01)

New classifications of female genital malignancies (FIGO and TNM)
由: E. V. Korzhevskaya, et al.
出版: (2014-08-01)

Primary ovarian cancer: possibilities for improving treatment outcomes
由: S. V. Khokhlova
出版: (2019-12-01)

Folic acid-conjugated mesoporous silica nanoparticles for enhanced therapeutic efficacy of topotecan in retina cancers
由: Qu W, et al.
出版: (2018-07-01)

Elucidation of Mechanisms of Topotecan-Induced Cell Death in Human Breast MCF-7 Cancer Cells by Gene Expression Analysis
由: Birandra K. Sinha, et al.
出版: (2020-07-01)